Edwards Lifesciences ROA 2010-2023 | EW
Current and historical return on assets (ROA) values for Edwards Lifesciences (EW) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Edwards Lifesciences ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2023-12-31 | $1.40B | $9.36B | 15.42% |
| 2023-09-30 | $1.43B | $9.37B | 16.21% |
| 2023-06-30 | $1.39B | $9.00B | 16.08% |
| 2023-03-31 | $1.49B | $8.65B | 17.51% |
| 2022-12-31 | $1.52B | $8.29B | 18.02% |
| 2022-09-30 | $1.46B | $8.64B | 17.17% |
| 2022-06-30 | $1.46B | $8.43B | 17.37% |
| 2022-03-31 | $1.54B | $8.42B | 18.80% |
| 2021-12-31 | $1.50B | $8.50B | 19.06% |
| 2021-09-30 | $1.48B | $8.16B | 19.53% |
| 2021-06-30 | $1.46B | $7.66B | 20.24% |
| 2021-03-31 | $0.85B | $7.21B | 12.30% |
| 2020-12-31 | $0.82B | $7.24B | 12.42% |
| 2020-09-30 | $0.79B | $6.80B | 12.32% |
| 2020-06-30 | $0.74B | $6.42B | 11.93% |
| 2020-03-31 | $1.11B | $6.08B | 18.39% |
| 2019-12-31 | $1.05B | $6.49B | 17.82% |
| 2019-09-30 | $0.77B | $5.97B | 13.86% |
| 2019-06-30 | $0.73B | $5.57B | 12.99% |
| 2019-03-31 | $0.77B | $5.47B | 13.66% |
| 2018-12-31 | $0.72B | $5.32B | 12.69% |
| 2018-09-30 | $0.71B | $5.96B | 12.33% |
| 2018-06-30 | $0.66B | $5.69B | 11.59% |
| 2018-03-31 | $0.56B | $5.83B | 10.13% |
| 2017-12-31 | $0.58B | $5.67B | 11.07% |
| 2017-09-30 | $0.75B | $5.49B | 14.96% |
| 2017-06-30 | $0.72B | $5.14B | 15.26% |
| 2017-03-31 | $0.66B | $4.78B | 14.86% |
| 2016-12-31 | $0.57B | $4.51B | 13.61% |
| 2016-09-30 | $0.55B | $4.34B | 13.55% |
| 2016-06-30 | $0.53B | $4.05B | 13.36% |
| 2016-03-31 | $0.52B | $3.85B | 13.38% |
| 2015-12-31 | $0.50B | $4.06B | 13.17% |
| 2015-09-30 | $0.46B | $3.88B | 12.78% |
| 2015-06-30 | $0.44B | $3.61B | 12.60% |
| 2015-03-31 | $0.87B | $3.49B | 25.54% |
| 2014-12-31 | $0.81B | $3.52B | 25.24% |
| 2014-09-30 | $0.78B | $3.35B | 25.82% |
| 2014-06-30 | $0.76B | $3.33B | 27.06% |
| 2014-03-31 | $0.31B | $2.65B | 11.92% |
| 2013-12-31 | $0.39B | $2.71B | 15.75% |
| 2013-09-30 | $0.40B | $2.53B | 17.17% |
| 2013-06-30 | $0.40B | $2.34B | 17.45% |
| 2013-03-31 | $0.37B | $2.30B | 16.84% |
| 2012-12-31 | $0.29B | $2.22B | 13.70% |
| 2012-09-30 | $0.27B | $2.20B | 12.84% |
| 2012-06-30 | $0.25B | $2.08B | 12.33% |
| 2012-03-31 | $0.24B | $2.00B | 11.94% |
| 2011-12-31 | $0.24B | $1.98B | 12.00% |
| 2011-09-30 | $0.24B | $1.98B | 12.44% |
| 2011-06-30 | $0.24B | $2.00B | 12.66% |
| 2011-03-31 | $0.24B | $1.93B | 13.31% |
| 2010-12-31 | $0.22B | $1.77B | 13.00% |
| 2010-09-30 | $0.20B | $1.73B | 12.27% |
| 2010-06-30 | $0.23B | $1.64B | 14.11% |
| 2010-03-31 | $0.22B | $1.60B | 13.87% |
| 2009-12-31 | $0.23B | $1.62B | 15.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $52.025B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.951B | 26.53 |
| Intuitive Surgical (ISRG) | United States | $133.132B | 80.20 |
| DexCom (DXCM) | United States | $49.242B | 74.90 |
| IQVIA Holdings (IQV) | United States | $42.631B | 25.28 |
| IDEXX Laboratories (IDXX) | United States | $41.469B | 49.58 |
| Alcon (ALC) | Switzerland | $38.841B | 28.64 |
| STERIS (STE) | Ireland | $20.148B | 23.85 |
| Waters (WAT) | United States | $18.463B | 26.49 |
| Hologic (HOLX) | United States | $17.835B | 19.68 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.800B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.341B | 85.27 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.795B | 14.57 |
| Sysmex ADR (SSMXY) | Japan | $10.000B | 31.36 |
| Teleflex (TFX) | United States | $9.736B | 15.29 |
| Penumbra (PEN) | United States | $7.923B | 97.80 |
| Masimo (MASI) | United States | $7.204B | 40.40 |
| Globus Medical (GMED) | United States | $6.843B | 21.70 |
| Glaukos (GKOS) | United States | $4.993B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.671B | 22.18 |
| TransMedics (TMDX) | United States | $3.012B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.996B | 19.76 |
| PROCEPT BioRobotics (PRCT) | United States | $2.664B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.629B | 18.04 |
| Nihon Kohden (NHNKY) | Japan | $2.417B | 20.44 |
| Tandem Diabetes Care (TNDM) | United States | $2.275B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.228B | 9.14 |
| Inari Medical (NARI) | United States | $2.227B | 384.20 |
| RxSight (RXST) | United States | $1.952B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.716B | 0.00 |
| Veracyte (VCYT) | United States | $1.450B | 0.00 |
| OPKO Health (OPK) | United States | $0.878B | 0.00 |
| Artivion (AORT) | United States | $0.847B | 97.95 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.836B | 15.47 |
| Paragon 28 (FNA) | United States | $0.730B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.720B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.697B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.642B | 0.00 |
| SiBone (SIBN) | United States | $0.598B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.557B | 18.90 |
| IRadimed (IRMD) | United States | $0.530B | 30.78 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.486B | 0.00 |
| Nevro (NVRO) | United States | $0.415B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.397B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.394B | 0.00 |
| NeuroPace (NPCE) | United States | $0.385B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.340B | 11.44 |
| CVRx (CVRX) | United States | $0.317B | 0.00 |
| AxoGen (AXGN) | United States | $0.290B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.270B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.262B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.233B | 0.00 |
| Accuray (ARAY) | United States | $0.217B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.192B | 0.00 |
| 908 Devices (MASS) | United States | $0.187B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.184B | 9.89 |
| Alpha Tau Medical (DRTS) | Israel | $0.168B | 0.00 |
| Inogen (INGN) | United States | $0.160B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.142B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.135B | 0.00 |
| Neuronetics (STIM) | United States | $0.105B | 0.00 |
| Envoy Medical (COCH) | United States | $0.102B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.100B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.098B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.069B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.061B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 113.67 |
| Vasomedical (VASO) | United States | $0.053B | 9.47 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| InspireMD (NSPR) | Israel | $0.047B | 0.00 |
| DarioHealth (DRIO) | United States | $0.044B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.041B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.016B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.016B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |